07Jan
DEAL WATCH: End-of-Year Biosimilar Agreements
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By:
Goodwin
Related
The holiday season is always a busy and eventful time, so you may have missed a new law that can imp...
Read More >
Earlier this week, the 4th Circuit Court of Appeals stayed construction of the Mountain Valley Pipel...
Read More >
The US Securities and Exchange Commission on May 20, 2020 adopted a series of amendments to its rule...
Read More >
In a new paper, Alternative Venture Capital: The New Unicorn Investors, professor Anat Alon-Beck exp...
Read More >
Prior to the outbreak of the COVID-19 pandemic, there had been a growing and global trend of establi...
Read More >
On the same day that the U.S. Department of Labor (DOL) filed a lawsuit against the Farmers National...
Read More >